参考文献/References:
[1].胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂 志,2019,34(3):209-220.
[2].Hachinohe D,Mitomo S,Candilio L.A practical approach to assessing stent results with IVUS or OCT[J].Methodist DeBakey Cardiovasc J,2018,14(1):32-41.
[3].Mintz GS,Guagliumi G. Intravascular imaging in coronary artery disease[J]. Lancet,2017,390(10096):793-809.
[4].Gill AE,Ciszak T,Braun H,et al. Intravascular ultrasound versus digital subtraction angiography:direct comparison of intraluminal diameter measurements in pediatric and adolescent imaging[J]. Pediatr Radiol,2017,47(4):450-457.
[5].Kwan TW,Yang S,Xu B,et al. Optimized quantitative angiographic and intravascular ultrasound parameters predicting the functional significance of single de novo lesions in the left anterior descending artery [J]. Chin Med J(Engl)，2012,125(23):4249-4253．
[6].王增良,杨树森.血管内超声在冠状动脉介入治疗中的应用进展[J]. 心血管病学进展,2012,33(3):349-352．
[7].Saito Y,Kobayashi Y,Fujii K,et al. Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from The Japanese Association of Cardiovascular Intervention and Therapeutics [J]. Cardiovasc Interv Ther,2020,35(1):1-12.
[8].Kang SJ,Mintz GS,Park DW,et al. Mechanisms of in-stent restenosis after durg-eluting stent implantation:intravascular ultrasound analysis[J]. Circ Cardiovasc Interv,2011,4(1):9-14．
[9].Witzenbichler B,Maehara A,Weisz G,et al. TCT-21 use of IVUS reduces stent thrombosis:results from the prospective,multicenter ADAPT-DES Study[J].J Am Coll Cardiol,2012,60(17):B6-B7.
[10].Nogourani MK,Moradi M,Khajouei AS,et al. Diagnostic value of intraluminal stent enhancement in estimating coronary in-stent restenosis[J]. J Clin Imaging Sci,2020 ,10:12.
[11].Thim T. Human -like atherosclerosis in minipigs:a new model for detection and treatment of vulnerable plaques[J]. Dan Med Bull ,2010,57(7):B4161．
[12].Kalidindi SR ,Tuzcu EM ,Nicholls SJ . Role of imaging end points in atherosclerosis trials:focus on intravascular ultrasound[J]. Int J Clin Pract,2007,61(6) :951-962.
[13].Colombo A,Moses JW,Morice MC,et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions[J].Circulation,2004,109(10):1244-1249．
[14].刘磊.血管内超声在分叉病变诊疗中的应用研究[J].齐齐哈尔医学院学报,2019,40(3):342-343.
[15].石晓辉.血管内超声联合冠状动脉造影在左主干病变中的应用价值[J].临床医学研究与实践,2019,4(28):21-23.
[16].Ghoshhajra BB,Takx RAP,Stone LL,et al. Real-time fusion of coronary CT angiography with X-ray fluoroscopy during chronic total occlusion PCI[J]. Eur Radiol,2017,27(6):2464-2473.
[17].叶剑飞,戴宇翔,李晨光,等.多排CT冠状动脉血管成像在冠状动脉慢性完全闭塞病变诊断中的应用[J]．中华全科医师杂志,2016,15(1):39-42．
[18].Inaba S,Mintz GS,Burke AP,et al. Intravascular ultrasound and near-infrared spectroscopic characterization of thin-cap fibroatheroma[J]. Am J Cardiol,2017, 119(3):372-378.
[19].蒋天红,朱吉平.血管内超声在冠状动脉慢性完全闭塞患者PCI术中的应用和安全性分析[J].中国医学前沿杂志(电子版),2019,11(10):162-165.
[20].王晓芳,陈海涛,杨丽春.血管内超声的临床应用进展[J]. 长治医学院学报 ,2012,26(2):158-160．
[21].Maurovich-Horvat P,Schlett CL,Alkadhi H,et al. Differentiation of early from advanced coronary atherosclerotic lesions:systematic comparison of CT ,intravascular US,and optical frequency domain imaging with histopathologic examination in ex vivo human hearts[J]. Radiology,2012,265(2):393-401.
[22].Sonoda S,Hibi K,Okura H,et al. Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions[J]. Cardiovasc Interv Ther,2020,35(1):30-36.
[23]. Pu J,Mintz GS,Biro S,et al. Insights into echo-attenuated plaques, echolucent plaques,and plaques with spotty calcification:novel findings from comparisons among intravascular ultrasound,near-infrared spectroscopy,and pathological histology in 2 294 human coronary artery segments[J]. J Am Coll Cardiol, 2014 ,63(21):2220-2233.
[24]. Dai X,Deng J,Yu M,et al. Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography:relationship with serum inflammatory marker level[J]. Int J Cardiovasc Imaging,2020,36(4):723-730.
[25].Hibi K,Kozuma K,Sonoda S,et al. A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by intravascular ultrasound[J]. JACC Cardiovasc Interv,2018,11(16) :1545-1555.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(11):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(11):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[3]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(11):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[4]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[5]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[6]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[7]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[8]陆鑫 张华.无载体含药物洗脱支架研究进展1[J].心血管病学进展,2019,(7):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
LU xinZHANG Hua.Polymer-free Drug-eluting Stent[J].Advances in Cardiovascular Diseases,2019,(11):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
[9]刘丹丹 王海珠 任凤波.ST段抬高型心肌梗死PCI术后血浆微囊泡浓度对再次血运重建的风险预测分析[J].心血管病学进展,2019,(7):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
LIU Dandan,WANG Haizhu,REN Fengbo.Predictive analysis of plasma microvesicles concentration in patients with ST-segment elevation myocardial infarction after target lesion revascularization[J].Advances in Cardiovascular Diseases,2019,(11):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
[10]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]